China-based private investigators receive prison terms

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

China-based private investigators receive prison terms

Peter Humphrey and Yu Yingzeng, the China-based investigators hired by GlaxoSmithKline to investigate corruption allegations, have been sentenced to 30 months and 24 months respectively for illegally obtaining private information

In a one-day trial, the Shanghai Intermediate Number One Court found that the British Humphrey (right) and Yu, his American wife, broke the law by illegally obtaining private information in the course of their investigations. In addition to the jail sentences, Humphrey received a RMB 200,000 fine ($32,500), while Yu was fined RMB 150,000. Humphrey will also be deported.

Humphrey and Yu have 10 days to appeal.

Donald Clarke of the Chinese Law Prof Blog has a copy of the Chinese language transcript posted by the court.

Humphrey and Yu are the founders of the private investigation firm ChinaWhys. In April 2013, GlaxoSmithKline hired the firm to investigate an anonymous email alleging that GSK employees were engaging in an elaborate bribery scheme. The detailed allegations also contained a video of GSK China head Mark Reilly in what appeared to be his Shanghai apartment.

In July 2013 Chinese authorities arrested Humphrey and Yu. Humphrey soon after issued an apology on Chinese television for his company's actions and said that he never intended to break Chinese law. GSK also admitted that its China-based executives had engaged in illegal activities.

The ChinaWhys case has been closely watched by international companies, as many regularly rely on private investigators to conduct due diligence on investments, business partners and other aspects of its business. This is especially true in IP enforcement, where companies often engage investigators to track down the sources of counterfeit goods.





more from across site and SHARED ros bottom lb

More from across our site

An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
With the London Annual Meeting behind us, we look back at some of the lessons learned this week and ahead to what 2027 will bring
Gift this article